chrisvoncsefalvay/vaers-outcomes huggingface dataset:
who got the first dose of the vaccine then tested positive for COVID-19 afterwards; who got the first dose of the vaccine then tested positive for COVID-19 afterwards; This is a spontaneous report from a Pfizer-sponsored program,  received from a contactable pharmacist. A patient of unspecified age and gender received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number not reported), on unspecified date at single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. It was reported that they had a patient who got first dose of the vaccine then tested positive for COVID-19 afterwards. Reporter wanted to know if the patient had to wait 10 or 90 days before he/she could get the second dose. The outcome of the events was unknown.  Information about lot/batch number has been requested.
Information has been received from a physician concerning a female who was vaccinated with Gardasil for the prevention of HPV. The patient received the Gardasil vaccination at her local OB/GYN office. A day after the patient received the vaccination, she had a regular check-up with her family physician, where she informed him of swelling at the site of injection after receiving the Gardasil vaccination. As of 13-JUL-2007, the outcome of the patient's swelling at the site of injection was unknown. Additional information has been requested.
Greater than 35 days between Moderna Covid-19 vaccinations; This spontaneous case was reported by a consumer and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Greater than 35 days between Moderna Covid-19 vaccinations) in an 83-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 036A21A and 041120A) for COVID-19 vaccination.     No Medical History information was reported.   On 28-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 17-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 17-Mar-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Greater than 35 days between Moderna Covid-19 vaccinations). At the time of the report, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Greater than 35 days between Moderna Covid-19 vaccinations) outcome was unknown.            No concomitant medications were reported.  It is mentioned that the patient did not reported any adverse reaction after her second dose.   No treatment medications were reported.   This case was linked to MOD-2022-501348 (Patient Link).
NauseaVomiting Mild site discomfort, Fatigue, chills Narrative:
patient felt chest pain 4 min after vaccination. Said that she felt anxious. EMS, medical provider and RN present with client and mother. V/S taken. 135/95, HR:95/min. Sat:97%. at 3:46PM.   AT 3 :53PM ,135/93, HR at 96/min ,SAT at 96%.   at 4:00PM patient feel better and less anxious with v/s at 119/87, HR 110/min and Sat at 94%.    At 4 02PM client is discharge by dr, with V/S at 128/83, HR 100/min and SAT at 94%.
Significant postural orthostatic tachycardia 150+ bpm (upon standing for more than 10 minutes) lasting over 10 days as well as occasionally while supine followed by shortness of air while tachycardic only; horrible and persistent headache unlike anything typical, distinct muscle aches and joint pain, nausea, dizziness/lightheadedness the worse of these lasting approximately 8 days and intermittent thereafter.
pt had a positive COVID test at Center for Rehab on 6/28/22; pt brought to hospital on 7/6/22 with worsening SOB secondary to COVID pneumonia; worsening respiratory requirements; 100% FiO2 via mask; ICU; worsening renal function; pt's condition continued to deteriorate; poor prognosis; steroids and ABX given; family requested comfort care; pt passed away  in the hospital
Numbness of the right leg; Pain; This spontaneous case was reported by a consumer and describes the occurrence of HYPOAESTHESIA (Numbness of the right leg) and PAIN (Pain) in a 61-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 046A21A) for COVID-19 vaccination.     The patient's past medical history included Gangrene (Gangrene on the same foot of 3 toe amputation), Heartburn, Surgical procedure (13 surgical procedures. Multiple surgeries in her knee, back and brain.) and Toe amputation (3 toe amputation). Concurrent medical conditions included Disability, Cardiovascular risk (Risk of stroke due to the pain), Pain (Pain due to an injury in 2019) since 2019, Stress, Anxiety and Inflammation.    On 18-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-Mar-2021, the patient experienced HYPOAESTHESIA (Numbness of the right leg) and PAIN (Pain). At the time of the report, HYPOAESTHESIA (Numbness of the right leg) and PAIN (Pain) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications include medications for stress, anxiety, pain and inflammation. Treatment information was not provided.   Most recent FOLLOW-UP information incorporated above includes: On 19-Apr-2021: Patient information updated. Historical condition and concomitant medication information updated. An event added.
Patient received vaccination and immediately felt uneasy (nauseous, lightheaded). The patient leaned over and became quiet and was not responding to questions. Patient then leaned back up and went stiff and had symptoms similar to that of a seizure (arms and legs went stiff and was unresponsive to questions) for about 30-60 seconds (at this time the paramedics had already been called). Patient then regained control and felt awful (a 5 on a scale of 1-10) and then felt even more nauseous and had to spit up into a trash can. Patient was given a water bottle to help them relax and cool off because patient felt warm. Paramedics arrived and checked blood pressure and pulse but found everything within normal ranges except for a slightly low blood pressure. The paramedics did nothing else except offer a scan of the patient's heart in their ambulance which he was then rolled out on a stretcher.
April 8, 2021  Modern NDC #80777-273-99  Lot #031A21A  Hx:  COPD, Heart Disease, Stent to R kidney  12:35   Patient received vaccine 12:40   Patient complained of ?hot? and dizzy with near syncopal event. Pt moved via wheelchair to bed.  Placed in supine position with legs elevated. Pt kept repeating she had COPD.  Respirations were rapid but no complaint of difficulty breathing.  EMS notified.   Vital signs:  BP 136/82   HR  70   O2 sat 98%   R 28 Pt sister, with patient at bedside.  Sister stated she has a history of anxiety. 12:50   EMS arrived.  Evaluated by EMS.  Respirations improving.  No longer feels hot and dizzy. 1:00   Patient signed refusal to transport with EMS 1:05   Patient sitting on side of bed.  No s/s of distress.  No shortness of breath or difficulty breathing. 1:15   Patient ambulated with assistance.    1:20  RN escorted pt to vehicle with sister driving and monitoring patient.   5:20 p.m.  Follow up phone call with patient:  No further issues.  VAERS AND ARIA reports filed  RN Infection Prevention and Control Health Dept
Sirva; Shut my arm DOWN; HIT A NERVE; It is like I have got a rotator cuff injury; This case was reported by a consumer via interactive digital media and described the occurrence of shoulder injury related to vaccine administration in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced shoulder injury related to vaccine administration, arm discomfort, nerve injury and rotator cuff injury. On an unknown date, the outcome of the shoulder injury related to vaccine administration, arm discomfort, nerve injury and rotator cuff injury were unknown.   It was unknown if the reporter considered the shoulder injury related to vaccine administration, arm discomfort, nerve injury and rotator cuff injury to be related to Shingles vaccine.  Additional details were provided as follows: The reporter was the patient. The age at vaccination was not reported. The patient stated that the vaccine shut their arm down and hit a nerve. The patient had SIRVA (shoulder injury related to vaccine administration) and also felt like they had got a rotator cuff injury. The patient was supposed to get the second dose in a few months and they were dreading it because they just don't know if they could handle it.
a lot of allergies to things and had to take Benadryl before each dose of the Pfizer COVID-19 vaccine; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A female patient received BNT162b2 (BNT162B2), as dose1, single (Batch/Lot number: unknown) and as dose2, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: DRUG HYPERSENSITIVITY (medically significant), outcome "unknown", described as "a lot of allergies to things and had to take Benadryl before each dose of the Pfizer COVID-19 vaccine". Therapeutic measures were taken as a result of drug hypersensitivity.  Clinical information: Inquiry made by reporter as that she heard there may be a new formulation of the Pfizer COVID-19 vaccine that is variant specific, she would like to know if this is true and when it might be available. Informed as omicron-specific Covid vaccine is an investigational product (not authorized). Inquiry made by her regarding rceiving the primary series and a first booster dose. She states that she is trying to decide on whether or not get the second booster dose that is now authorized and would like to know how long the second booster dose provides protection against COVID-19. The caller also stated that she "a lot of allergies to things and had to take Benadryl before each dose of the Pfizer COVID-19 vaccine" The caller also stated that she was fine with each dose.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
17 minutes after vaccination, patient started having itching and tightness to face. Started with a few hives to right cheek. Benadryl 25 mg IM given and patient sent to emergency department
''My'' armpit started to hurt and it moved into my left breast. It hurt to the touch or to move; ''I'' read up on it and they call it Lymphadenopathy; This is a spontaneous report from a contactable consumer, the patient. A 42-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE;Lot Number: EN6203) via an unspecified route of administration in the left arm on 01Mar2021 at 09:45 (at the age of 42-years-old) as a single dose for COVID-19 immunisation. Medical history included high cholesterol. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19.The patient did not receive any other vaccine within four weeks prior to the COVID vaccine. The patient received unspecified medication within two weeks of vaccination. On 02Mar2021 at 11:00, the patient experienced armpit started to hurt and it moved into her left breast. It hurt to the touch or to move. On 03Mar2021, the patient still felt it but not as bad. The patient would see how she felt throughout the day. She read up on it and called it Lymphadenopathy. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. No therapeutic measures were taken as a result of the reported events. The clinical outcome of the events armpit started to hurt and lymphadenopathy was unknown at the time of this report.   No follow-up attempts are needed. No further information is expected.
This spontaneous case was reported by a consumer and describes the occurrence of ADVERSE EVENT (pharmacist got worse with second shot) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced ADVERSE EVENT (pharmacist got worse with second shot). At the time of the report, ADVERSE EVENT (pharmacist got worse with second shot) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No treatment details were reported.
pt recv flu vax but also inadvertently recv another inj of flu shield intradermally;pt devel pain & redness @ the site of intradermal inj;addtl info was recv 6NOV96;pt was treated w/cortisone cream & resolved;
extreme irritability, fussiness and inconsolable crying for more than 30 minutes, 2-3 times a day for 4 days
Myalgia, dry heaves, arthralgias, malaise for 12-18 hours.
pain got worse; pain in thighs; severe long-lasting and bizarre symptoms; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (pain got worse), PAIN IN EXTREMITY (pain in thighs) and ABNORMAL BEHAVIOUR (severe long-lasting and bizarre symptoms) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PAIN (pain got worse), PAIN IN EXTREMITY (pain in thighs) and ABNORMAL BEHAVIOUR (severe long-lasting and bizarre symptoms). At the time of the report, PAIN (pain got worse), PAIN IN EXTREMITY (pain in thighs) and ABNORMAL BEHAVIOUR (severe long-lasting and bizarre symptoms) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No Concomitant medication were reported. No Treatment information was reported.
Small blisters, itching, burning, now red dots both arms from shoulder to elbow and upper back and chest. Started 12/1/2017 and remains.
Light fever on evening of shot then achiness like flu symptoms, then fever spiked during the evening and around 10:00AM on Feb. 10, the fever had reached 102.  But, by 10:00 PM that evening it was 98.6.  I returned to work on Feb. 11 and 12.  Then on Feb. 13, I developed a severe pain in my chest and back area and it persisted all day and thru the night.  I could only sleep sitting up.  The pain was pretty severe when I laid down flat on my back.  On Feb. 15 at 7:00 AM my wife insisted I go to the ER .  Initially, their computer showed I had a heart attack.  So, I was admitted for Observation on Monday evening and Tue. morning the Dr. admitted me to the hospital and a heart cath. was conducted and ruled out that I had a heart attack, but they are treating me Pirocarditis.  I feel that this is a side effect of the second vaccine since I have NEVER had any heart concerns prior to this.
5 hr after shot fever 101 chills severe headache body ache. Next day fever came down to 100 but still had headach and took tylenol both days.
WEIRD SPINNING; SUSPECTED CLINICAL VACCINATION FAILURE; SUSPECTED COVID-19 INFECTION/FEVER/SPLITTING HEADACHE/SINUS PRESSURE/COUGH/CONGESTION/FEELING SICK; FELT ROTTEN AFTER THE SHOT/FELT LIKE BRAIN WAS FLOATING IN HOT WATER; This spontaneous report received from a patient concerned a 51 year old female. Initial information was processed along with the additional information received on 26-JUL-2021 The patient's height, and weight were not reported. The patient's past medical history included Lyme disease, and concurrent conditions included non-smoker, alcohol user (Occasional glass of wine), and penicillin allergy. The patient was not pregnant at the time of reporting. The patient had no history of drug abuse or illicit drug usage. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 205A21A, and expiry: 07-AUG-2021) dose was not reported, 1 total administered to left arm on 16-MAY-2021 for prophylactic vaccination. Concomitant medications included vitamins nos.  On 16-MAY-2021, after the vaccination, the patient felt rotten for a day and a half but no other side effects. On 23-JUL-2021, the patient started experiencing fever, splitting headache and sinus pressure. On 24-JUL-2021, the patient went to get a rapid covid-19 test and result came as positive to Covid-19 (suspected covid-19 infection and suspected clinical vaccination failure). The patient also had symptoms such as congestion, headache, and cough which was present at the time of reporting. It was reported that, the patient's symptoms were like waves sometimes she felt better then she felt sick. The patient stated that her fever was 99 F and not more than 100 F. The patient also stated that she felt like her brain was floating in hot water and felt weird spinning.  The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from felt rotten after the shot/felt like brain was floating in hot water on MAY-2021, had not recovered from suspected covid-19 infection/fever/splitting headache/sinus pressure/cough/congestion/feeling sick, and the outcome of suspected clinical vaccination failure and weird spinning was not reported. This report was serious (Other Medically Important Condition). This report was associated with product complaint number 90000187262. The suspected product quality complaint has been confirmed to be not voided (meet PQC) based on the PQC evaluation/investigation performed.; Sender's Comments: V0: 20210755349-COVID-19 VACCINE AD26.COV2.S-Suspected clinical  vaccination failure. This event is considered not related. The event has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There are other factors more likely to be associated with the event than the drug. Specifically: SPECIAL SITUATIONS
This spontaneous report was received from a medical assistant and refers to an unspecified number of patients of unknown age and gender. The patient's pertinent medical history, drug reactions or allergies and concomitant medications were not reported. On unknown dates, the patients were vaccinated with unspecified amount of improperly stored doses of PNEUMOVAX 23, lot # K007262, expiration date 25-NOV-2015 (dose, route of administration and indication were not provided). No adverse effects were reported. Additional information has been requested.
lightheadedness; This is a spontaneous report from a non-contactable health care professional (other HCP). A 23-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection; Batch/Lot Number: EN6205; Expiration date was not reported), via an unspecified route of administration on an unspecified date (at the age of 23-years-old) as first dose, single dose for COVID-19 immunisation. Medical history included lightheaded from an unknown date and unknown if ongoing; it was reported that the patient stated the he always gets lightheaded when he gets a shot. The patient's concomitant medications were not reported. On an unspecified date, during the patient's 15-minute waiting period after the injection, the patient experienced lightheadedness. The patient denied difficulty breathing, difficulty swallowing, throat tightness, nausea and any episodes of syncope in the past. The outcome of the event was recovered on an unspecified date; lightheadedness resolved prior to discharge.  No follow-up attempts are possible. No further information is expected.
Cataract; appeared to have aged significantly with; Appeared to have aged significantly overnight with more gray hair; More lines on face / More lines on lips; This spontaneous case was reported by a consumer and describes the occurrence of CATARACT (Cataract) in a 79-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 032120A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Cataract.   On 25-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 20-May-2021, the patient experienced HAIR COLOUR CHANGES (Appeared to have aged significantly overnight with more gray hair) and SKIN WRINKLING (More lines on face / More lines on lips). On an unknown date, the patient experienced CATARACT (Cataract) (seriousness criterion medically significant) and PREMATURE AGEING (appeared to have aged significantly with). The patient was treated with Surgery for Cataract. At the time of the report, CATARACT (Cataract), HAIR COLOUR CHANGES (Appeared to have aged significantly overnight with more gray hair), SKIN WRINKLING (More lines on face / More lines on lips) and PREMATURE AGEING (appeared to have aged significantly with) outcome was unknown. Not Provided          No concomitant medication was provided.  No treatment medication was provided.  The action taken for m-RNA-1273 Covid-19 Moderna Vaccine was not applicable.  On 19-MAY-2021 (reported as 19-MAY), the patient had her first cataract surgery. The following day, she was shocked when she looked at the mirror as she appeared to have aged significantly overnight. The patient stated that she could only think of the vaccine she had and the anesthesia from the cataract surgery. It was unknown if the patient was treated for the events more gray hair and more lines on her face and lips.  Very limited information regarding this event has been provided at this time; Sender's Comments: Very limited information regarding this event has been provided at this time
Arm pain began 4 hours after receiving 2nd dose of vaccine and flu like symptoms arrived 10 hours after receiving vaccine. Symptoms started with chills and sensitive skin and then fever of 100 and body/joint aches and pain. Symptoms lasted for about 24 hours. Second day after vaccine, symptoms consisted of a headache only.
Patient admitted with COVID-19 Breakthrough case on 10/13/21.  Presented with AMS and hyperglycemia.
Pt given FLUARIX in the right deltoid, immediately after large lump was noticed by nurse along w/some bleeding. Dr spoke w/pt, decided pt should wait 15 min to make sure bump went down.